Abstract
Cancer is a multifaceted disease comprising a combination of genetic, metabolic and signalling aberrations, which severely disrupt the normal homeostasis of cell growth and death. Many oncogenic events while promoting tumour development also increase the sensitivity of cells to cell death stimuli including chemotherapeutic drugs. As a result, tumour cells often acquire the ability to evade death by inactivating cell death pathways that normally function to eliminate damaged and harmful cells. The impairment of cell death function is also often the reason for the development of chemotherapeutic resistance encountered during treatment. It is therefore necessary to achieve a comprehensive understanding of existing cell death pathways and the relevant regulatory components involved, with the intention of identifying new strategies to kill cancer cells. This review provides an insightful overview of the common forms of cell death signalling pathways, the interactions between these pathways and the ways in which these pathways are deregulated in cancer. We also discuss the emerging therapies targeted at activating or restoring cell death pathways to induce tumour cell death, which are currently being tested in clinical trials.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amaravadi RK, Thompson CB . (2007). The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 13: 7271–7279.
Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI et al. (2007). Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117: 326–336.
Artal-Sanz M, Samara C, Syntichaki P, Tavernarakis N . (2006). Lysosomal biogenesis and function is critical for necrotic cell death in Caenorhabditis elegans. J Cell Biol 173: 231–239.
Ashkenazi A, Dixit VM . (1998). Death receptors: signaling and modulation. Science 281: 1305–1308.
Azad MB, Chen Y, Henson ES, Cizeau J, McMillan-Ward E, Israels SJ et al. (2008). Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 4: 195–204.
Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M et al. (2009). Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 119: 1109–1123.
Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J et al. (2009). Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3 L via their BH3 domains. Mol Cell Biol 29: 2570–2581.
Berry DL, Baehrecke EH . (2007). Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila. Cell 131: 1137–1148.
Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J et al. (2008). cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30: 689–700.
Bianchi K, Meier P . (2009). A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling. Mol Cell 36: 736–742.
Boya P, Kroemer G . (2008). Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434–6451.
Briceno E, Calderon A, Sotelo J . (2007). Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme. Surg Neurol 67: 388–391.
Bykov VJ, Issaeva N, Shilov A, Hultcrantz M, Pugacheva E, Chumakov P et al. (2002). Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nat Med 8: 282–288.
Bykov VJ, Zache N, Stridh H, Westman J, Bergman J, Selivanova G et al. (2005). PRIMA-1(MET) synergizes with cisplatin to induce tumor cell apoptosis. Oncogene 24: 3484–3491.
Cain K, Bratton SB, Langlais C, Walker G, Brown DG, Sun XM et al. (2000). Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. J Biol Chem 275: 6067–6070.
Chan DA, Giaccia AJ . (2011). Harnessing synthetic lethal interactions in anticancer drug discovery. Nat Rev Drug Discov 10: 351–364.
Chan FK, Shisler J, Bixby JG, Felices M, Zheng L, Appel M et al. (2003). A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 278: 51613–51621.
Chautan M, Chazal G, Cecconi F, Gruss P, Golstein P . (1999). Interdigital cell death can occur through a necrotic and caspase-independent pathway. Curr Biol 9: 967–970.
Chen DJ, Huerta S . (2009). Smac mimetics as new cancer therapeutics. Anticancer Drugs 20: 646–658.
Ch'en IL, Tsau JS, Molkentin JD, Komatsu M, Hedrick SM . (2011). Mechanisms of necroptosis in T cells. J Exp Med 208: 633–641.
Cheung WC, Kim JS, Linden M, Peng L, Van Ness B, Polakiewicz RD et al. (2004). Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice. J Clin Invest 113: 1763–1773.
Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR . (2005). PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309: 1732–1735.
Chipuk JE, Green DR . (2008). How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157–164.
Cho DH, Jo YK, Hwang JJ, Lee YM, Roh SA, Kim JC . (2009a). Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells. Cancer Lett 274: 95–100.
Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M et al. (2009b). Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112–1123.
Ciechomska IA, Goemans GC, Skepper JN, Tolkovsky AM . (2009). Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function. Oncogene 28: 2128–2141.
Cragg MS, Harris C, Strasser A, Scott CL . (2009). Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics. Nat Rev Cancer 9: 321–326.
Cragg MS, Jansen ES, Cook M, Harris C, Strasser A, Scott CL . (2008). Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic. J Clin Invest 118: 3651–3659.
Cragg MS, Kuroda J, Puthalakath H, Huang DC, Strasser A . (2007). Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. PLoS Med 4: 1681–1689; discussion 1690.
Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR et al. (2006). DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121–134.
Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G et al. (2006). Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51–64.
Degterev A, Boyce M, Yuan J . (2003). A decade of caspases. Oncogene 22: 8543–8567.
Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N et al. (2005). Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 1: 112–119.
Delavallee L, Cabon L, Galan-Malo P, Lorenzo HK, Susin SA . (2011). AIF-mediated caspase-independent necroptosis: a new chance for targeted therapeutics. IUBMB Life 63: 221–232.
Deter RL, Baudhuin P, De Duve C . (1967). Participation of lysosomes in cellular autophagy induced in rat liver by glucagon. J Cell Biol 35: C11–C16.
Deveraux QL, Takahashi R, Salvesen GS, Reed JC . (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300–304.
Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z . (2000). The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12: 419–429.
Djavaheri-Mergny M, Maiuri MC, Kroemer G . (2010). Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene 29: 1717–1719.
Du C, Fang M, Li Y, Li L, Wang X . (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33–42.
Eguchi Y, Shimizu S, Tsujimoto Y . (1997). Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57: 1835–1840.
Elmore S . (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495–516.
Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM . (1998). The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ 5: 551–562.
Fanidi A, Harrington EA, Evan GI . (1992). Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554–556.
Fecker LF, Geilen CC, Tchernev G, Trefzer U, Assaf C, Kurbanov BM et al. (2006). Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis. J Invest Dermatol 126: 1366–1371.
Feoktistova M, Geserick P, Kellert B, Dimitrova DP, Langlais C, Hupe M et al. (2011). cIAPs block ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol Cell 43: 449–463.
Fimia GM, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R et al. (2007). Ambra1 regulates autophagy and development of the nervous system. Nature 447: 1121–1125.
Fulda S, Debatin KM . (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798–4811.
Fulda S, Meyer E, Debatin KM . (2002). Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21: 2283–2294.
Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH et al. (2009). Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 16: 1093–1107.
Gdynia G, Grund K, Eckert A, Bock BC, Funke B, Macher-Goeppinger S et al. (2007). Basal caspase activity promotes migration and invasiveness in glioblastoma cells. Mol Cancer Res 5: 1232–1240.
Ghavami S, Hashemi M, Ande SR, Yeganeh B, Xiao W, Eshraghi M et al. (2009). Apoptosis and cancer: mutations within caspase genes. J Med Genet 46: 497–510.
Green DR, Evan GI . (2002). A matter of life and death. Cancer Cell 1: 19–30.
Greenhalgh DG . (1998). The role of apoptosis in wound healing. Int J Biochem Cell Biol 30: 1019–1030.
Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G et al. (2011). Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25: 460–470.
Gyrd-Hansen M, Meier P . (2010). IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10: 561–574.
Hanahan D, Weinberg RA . (2000). The hallmarks of cancer. Cell 100: 57–70.
He S, Wang L, Miao L, Wang T, Du F, Zhao L et al. (2009). Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 137: 1100–1111.
Healy E, Dempsey M, Lally C, Ryan MP . (1998). Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line. Kidney Int 54: 1955–1966.
Helgason GV, Karvela M, Holyoake TL . (2011). Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 118: 2035–2043.
Hengartner MO . (2000). The biochemistry of apoptosis. Nature 407: 770–776.
Hetschko H, Voss V, Seifert V, Prehn JH, Kogel D . (2008). Upregulation of DR5 by proteasome inhibitors potently sensitizes glioma cells to TRAIL-induced apoptosis. FEBS J 275: 1925–1936.
Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ . (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334–336.
Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S et al. (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1: 489–495.
Hou W, Han J, Lu C, Goldstein LA, Rabinowich H . (2010). Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis. Autophagy 6: 891–900.
Hunter AM, LaCasse EC, Korneluk RG . (2007). The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543–1568.
Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T et al. (2000). LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720–5728.
Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R et al. (2011). RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471: 368–372.
Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Kim SS et al. (2009). Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol 217: 702–706.
Kerr JF, Wyllie AH, Currie AR . (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257.
Kirkin V, Lamark T, Sou YS, Bjorkoy G, Nunn JL, Bruun JA et al. (2009). A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 33: 505–516.
Koneri K, Goi T, Hirono Y, Katayama K, Yamaguchi A . (2007). Beclin 1 gene inhibits tumor growth in colon cancer cell lines. Anticancer Res 27: 1453–1457.
Koschny R, Holland H, Sykora J, Haas TL, Sprick MR, Ganten TM et al. (2007). Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Clin Cancer Res 13: 3403–3412.
Kosta A, Roisin-Bouffay C, Luciani MF, Otto GP, Kessin RH, Golstein P . (2004). Autophagy gene disruption reveals a non-vacuolar cell death pathway in Dictyostelium. J Biol Chem 279: 48404–48409.
Kuroda J, Puthalakath H, Cragg MS, Kelly PN, Bouillet P, Huang DC et al. (2006). Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proc Natl Acad Sci USA 103: 14907–14912.
Lavrik I, Golks A, Krammer PH . (2005). Death receptor signaling. J Cell Sci 118: 265–267.
Lee JT, Innes Jr DJ, Williams ME . (1989). Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma. J Clin Invest 84: 1454–1459.
Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P . (1997). Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185: 1481–1486.
Leontieva OV, Gudkov AV, Blagosklonny MV . (2010). Weak p53 permits senescence during cell cycle arrest. Cell Cycle 9: 4323–4327.
Leu JI, Dumont P, Hafey M, Murphy ME, George DL . (2004). Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 6: 443–450.
Levine B, Yuan J . (2005). Autophagy in cell death: an innocent convict? J Clin Invest 115: 2679–2688.
Li G, Ho VC . (1998). p53-dependent DNA repair and apoptosis respond differently to high- and low-dose ultraviolet radiation. Br J Dermatol 139: 3–10.
Li H, Zhu H, Xu CJ, Yuan J . (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491–501.
Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH et al. (2006). Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8: 688–699.
Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H et al. (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672–676.
Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G et al. (1998). Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72: 8586–8596.
Lieberthal W, Triaca V, Levine J . (1996). Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs necrosis. Am J Physiol 270: F700–F708.
Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS et al. (2004). Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 279: 10822–10828.
Lin Y, Devin A, Rodriguez Y, Liu ZG . (1999). Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13: 2514–2526.
Lowe SW, Cepero E, Evan G . (2004). Intrinsic tumour suppression. Nature 432: 307–315.
Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T et al. (2005). Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120: 237–248.
Luo S, Rubinsztein DC . (2010). Apoptosis blocks Beclin 1-dependent autophagosome synthesis: an effect rescued by Bcl-xL. Cell Death Differ 17: 268–277.
Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481–490.
Maiuri MC, Criollo A, Tasdemir E, Vicencio JM, Tajeddine N, Hickman JA et al. (2007a). BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy 3: 374–376.
Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P et al. (2007b). Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 26: 2527–2539.
Marino G, Salvador-Montoliu N, Fueyo A, Knecht E, Mizushima N, Lopez-Otin C . (2007). Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 282: 18573–18583.
Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR et al. (2002). The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 277: 439–444.
Massoumi R, Chmielarska K, Hennecke K, Pfeifer A, Fassler R . (2006). Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling. Cell 125: 665–677.
Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY et al. (2009). Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062–1075.
Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K et al. (2007). Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21: 1367–1381.
Matsunaga K, Saitoh T, Tabata K, Omori H, Satoh T, Kurotori N et al. (2009). Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 11: 385–396.
Mayer B, Oberbauer R . (2003). Mitochondrial regulation of apoptosis. News Physiol Sci 18: 89–94.
McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP et al. (1989). bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57: 79–88.
McDonnell TJ, Korsmeyer SJ . (1991). Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349: 254–256.
McKenzie S, Kyprianou N . (2006). Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J Cell Biochem 97: 18–32.
Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW et al. (2002). The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 277: 45162–45171.
Micheau O, Tschopp J . (2003). Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181–190.
Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. (2003). p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11: 577–590.
Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I et al. (2007). Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 30: 429–436.
Miura M . (2011). Active participation of cell death in development and organismal homeostasis. Dev Growth Differ 53: 125–136.
Mizushima N, Ohsumi Y, Yoshimori T . (2002). Autophagosome formation in mammalian cells. Cell Struct Funct 27: 421–429.
Mizushima N, Levine B, Cuervo AM, Klionsky DJ . (2008). Autophagy fights disease through cellular self-digestion. Nature 451: 1069–1075.
Mortimore GE, Schworer CM . (1977). Induction of autophagy by amino-acid deprivation in perfused rat liver. Nature 270: 174–176.
Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M et al. (1998). p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 188: 2033–2045.
Nakano K, Vousden KH . (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683–694.
Novikoff AB, Essner E, Quintana N . (1964). Golgi apparatus and lysosomes. Fed Proc 23: 1010–1022.
O'Donnell MA, Perez-Jimenez E, Oberst A, Ng A, Massoumi R, Xavier R et al. (2011). Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol 13: 1437–1442.
Oberst A, Dillon CP, Weinlich R, McCormick LL, Fitzgerald P, Pop C et al. (2011). Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 471: 363–367.
Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. (2000). Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053–1058.
Odonkor CA, Achilefu S . (2008). Differential activity of caspase-3 regulates susceptibility of lung and breast tumor cell lines to Paclitaxel. Open Biochem J 2: 121–128.
Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, Thompson CB et al. (1997). Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am 3: 230–237.
Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA et al. (2005). An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435: 677–681.
Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H et al. (2007). p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131–24145.
Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N et al. (2005). Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927–939.
Pavet V, Portal MM, Moulin JC, Herbrecht R, Gronemeyer H . (2011). Towards novel paradigms for cancer therapy. Oncogene 30: 1–20.
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A et al. (2003). Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809–1820.
Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC et al. (1997). Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967–969.
Rosenfeldt MT, Ryan KM . (2009). The role of autophagy in tumour development and cancer therapy. Expert Rev Mol Med 11: e36.
Rosenfeldt MT, Ryan KM . (2011). The multiple roles of autophagy in cancer. Carcinogenesis 32: 955–963.
Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P . (2004). Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861–2874.
Salvesen GS, Renatus M . (2002). Apoptosome: the seven-spoked death machine. Dev Cell 2: 256–257.
Samara C, Syntichaki P, Tavernarakis N . (2008). Autophagy is required for necrotic cell death in Caenorhabditis elegans. Cell Death Differ 15: 105–112.
Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS . (2002). BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 4: 842–849.
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. (1998). Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675–1687.
Schmitt CA, Lowe SW . (1999). Apoptosis and therapy. J Pathol 187: 127–137.
Scholl C, Frohling S, Dunn IF, Schinzel AC, Barbie DA, Kim SY et al. (2009). Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 137: 821–834.
Schwarze PE, Seglen PO . (1985). Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats. Exp Cell Res 157: 15–28.
Shen S, Kepp O, Michaud M, Martins I, Minoux H, Metivier D et al. (2011). Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene 30: 4544–4556.
Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB et al. (2004). Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6: 1221–1228.
Shiraishi H, Okamoto H, Hara H, Yoshida H . (2010). Alternative cell death of Apaf1-deficient neural progenitor cells induced by withdrawal of EGF or insulin. Biochim Biophys Acta 1800: 405–415.
Shivapurkar N, Toyooka S, Eby MT, Huang CX, Sathyanarayana UG, Cunningham HT et al. (2002). Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther 1: 65–69.
Solary E, Dubrez L, Eymin B . (1996). The role of apoptosis in the pathogenesis and treatment of diseases. Eur Respir J 9: 1293–1305.
Soldani C, Scovassi AI . (2002). Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7: 321–328.
Solomon VR, Lee H . (2009). Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 625: 220–233.
Soria JC, Mark Z, Zatloukal P, Szima B, Albert I, Juhasz E et al. (2011). Randomized Phase II study of Dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer. J Clin Oncol 29: 4442–4451.
Tait SW, Green DR . (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11: 621–632.
Takahashi Y, Coppola D, Matsushita N, Cualing HD, Sun M, Sato Y et al. (2007). Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol 9: 1142–1151.
Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S et al. (2011). Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25: 795–800.
Takimoto R, El-Deiry WS . (2000). Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 19: 1735–1743.
Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M et al. (2008). Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 10: 676–687.
Temkin V, Huang Q, Liu H, Osada H, Pope RM . (2006). Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol Cell Biol 26: 2215–2225.
Tenev T, Bianchi K, Darding M, Broemer M, Langlais C, Wallberg F et al. (2011). The ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol Cell 43: 432–448.
Thornborrow EC, Patel S, Mastropietro AE, Schwartzfarb EM, Manfredi JJ . (2002). A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene 21: 990–999.
Tsujimoto Y, Cossman J, Jaffe E, Croce CM . (1985). Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440–1443.
Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM . (1984). Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097–1099.
Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G . (2010). Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11: 700–714.
Vaux DL, Cory S, Adams JM . (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440–442.
Vercammen D, Beyaert R, Denecker G, Goossens V, Van Loo G, Declercq W et al. (1998a). Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med 187: 1477–1485.
Vercammen D, Brouckaert G, Denecker G, Van de Craen M, Declercq W, Fiers W et al. (1998b). Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med 188: 919–930.
Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE et al. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43–53.
Walczak H, Krammer PH . (2000). The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256: 58–66.
Wiman KG . (2010). Pharmacological reactivation of mutant p53: from protein structure to the cancer patient. Oncogene 29: 4245–4252.
Wright A, Reiley WW, Chang M, Jin W, Lee AJ, Zhang M et al. (2007). Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD. Dev Cell 13: 705–716.
Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM . (2001). Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 20: 240–251.
Wu YT, Tan HL, Huang Q, Kim YS, Pan N, Ong WY et al. (2008). Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy 4: 457–466.
Wu YT, Tan HL, Huang Q, Sun XJ, Zhu X, Shen HM . (2011). zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFalpha mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ 18: 26–37.
Yang S, Wang X, Contino G, Liesa M, Sahin E, Ying H et al. (2011). Pancreatic cancers require autophagy for tumor growth. Genes Dev 25: 717–729.
Yang Y, Hu W, Feng S, Ma J, Wu M . (2005). RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis. Biochem Biophys Res Commun 332: 181–187.
Yang Z, Klionsky DJ . (2010). Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814–822.
Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T . (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385: 637–640.
Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S et al. (2004). Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304: 1500–1502.
Yue Z, Jin S, Yang C, Levine AJ, Heintz N . (2003). Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100: 15077–15082.
Zeng H, Zhang S, Yang KY, Wang T, Hu JL, Huang LL et al. (2010). Knockdown of second mitochondria-derived activator of caspase expression by RNAi enhances growth and cisplatin resistance of human lung cancer cells. Cancer Biother Radiopharm 25: 705–712.
Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC et al. (2009). RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325: 332–336.
Zhang H, Zhou X, McQuade T, Li J, Chan FK, Zhang J . (2011). Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature 471: 373–376.
Zhang J, Stirling B, Temmerman ST, Ma CA, Fuss IJ, Derry JM et al. (2006). Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J Clin Invest 116: 3042–3049.
Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB . (2004). Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 18: 1272–1282.
Acknowledgements
We apologise to researchers whose studies we were unable to cite due to the length of this review. We thank the members of the Tumour Cell Death Laboratory for critical reading of the manuscript. Work in the Tumour Cell Death Laboratory is supported by Cancer Research UK and the Association for International Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Long, J., Ryan, K. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Oncogene 31, 5045–5060 (2012). https://doi.org/10.1038/onc.2012.7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.7
Keywords
This article is cited by
-
RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer
Cancer Cell International (2023)
-
The mechanism of programmed death and endoplasmic reticulum stress in pulmonary hypertension
Cell Death Discovery (2023)
-
Necrocide 1 mediates necrotic cell death and immunogenic response in human cancer cells
Cell Death & Disease (2023)
-
Zinc Acts Synergistically with Berberine for Enhancing Its Efficacy as an Anti-cancer Agent by Inducing Clusterin-Dependent Apoptosis in HT-29 Colorectal Cancer Cells
Biological Trace Element Research (2023)
-
Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns
Journal of Cancer Research and Clinical Oncology (2023)
